Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
220.7 CHF | -0.05% | -1.35% | -9.54% |
15/07 | ROCHE HOLDINGS AG : Sell rating from Goldman Sachs | ZD |
15/07 | ROCHE HOLDINGS AG : Gets a Neutral rating from Deutsche Bank | ZD |
Chart calendar Roche Holding AG
Upcoming events on Roche Holding AG
Past events on Roche Holding AG
18/06/2024 12:30 pm | Citi European Healthcare Conference |
16/06/2024 04:30 pm | European Hematology Association Congress |
11/06/2024 05:30 pm | Goldman Sachs Global Healthcare Conference |
06/06/2024 11:30 am | Vontobel Swiss Equity Leadership Conference |
06/06/2024 11:30 am | BNP Paribas Exane CEO Conference |
05/06/2024 05:30 pm | Jefferies Global Healthcare Conference |
31/05/2024 07:30 pm | American Society of Clinical Oncology Meeting |
29/05/2024 05:30 pm | Bernstein Strategic Decisions Conference |
23/05/2024 11:30 am | Deutsche Bank dbAccess European Champions Conference |
22/05/2024 05:30 pm | Investor Day |
15/05/2024 12:30 pm | Berenberg Diagnostics Conference |
14/05/2024 10:30 pm | BofA Securities Health Care Conference |
24/04/2024 05:30 pm | Q1 2024 Sales and Revenue Call |
24/04/2024 10:30 am | Q1 2024 Sales and Revenue Release |
26/03/2024 01:30 pm | BNP Exane Healthcare Conference |
21/03/2024 01:30 pm | Kepler Cheuvreux Swiss Seminar |
14/03/2024 | Détachement de for final dividend |
12/03/2024 07:30 pm | Barclays Global Healthcare Conference |
12/03/2024 03:00 pm | Annual General Meeting |
11/03/2024 07:30 pm | Investor Meeting - Neurology |
Past dividends on Roche Holding AG
14/03/2024 | Annual 9.6 CHF |
16/03/2023 | Annual 9.5 CHF |
17/03/2022 | Annual 9.3 CHF |
18/03/2021 | Annual 9.1 CHF |
19/03/2020 | Annual 9 CHF |
07/03/2019 | Annual 8.7 CHF |
15/03/2018 | Annual 8.3 CHF |
16/03/2017 | Annual 8.2 CHF |
03/03/2016 | Annual 8.1 CHF |
05/03/2015 | 8 CHF |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 61 466 61 789 -0.52% | 58 323 59 276 -1.61% | 62 801 62 237 0.91% | 63 281 63 332 -0.08% | 58 716 59 502 -1.32% | 60 471 |
EBITDA Million CHF | Released Forecast Spread | 25 419 24 199 5.04% | 24 281 24 532 -1.02% | 24 692 25 569 -3.43% | 25 015 24 644 1.51% | 21 976 22 765 -3.46% | 22 690 |
EBIT Million CHF | Released Forecast Spread | 22 479 22 680 -0.89% | 21 536 21 622 -0.4% | 21 897 22 784 -3.89% | 22 173 22 200 -0.12% | 19 240 19 957 -3.59% | 20 079 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 16 614 18 369 -9.56% | 17 965 18 289 -1.77% | 17 398 20 328 -14.41% | 16 327 19 694 -17.1% | 14 079 17 867 -21.2% | 17 726 |
Net income Million CHF | Released Forecast Spread | 13 497 14 257 -5.33% | 14 295 14 335 -0.28% | 13 930 15 065 -7.53% | 12 421 14 442 -13.99% | 11 498 13 584 -15.35% | 13 431 |
EPS CHF | Released Forecast Spread | 15,6 16,6 -5.73% | 16,5 16,5 -0.02% | 16,2 17,8 -9.22% | 15,4 17,9 -14.08% | 14,3 17,0 -15.74% | 17,1 |
Announcement Date | 30/01/20 | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 S1 | 2025 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 30 997 31 426 -1.37% | 29 281 30 369 -3.58% | 29 042 30 037 -3.31% | 30 713 30 038 2.25% | 16 117 15 745 2.36% | 32 088 31 791 0.93% | 16 445 16 072 2.32% | 15 850 15 474 2.43% | 32 295 31 869 1.34% | 14 742 15 274 -3.48% | 16 244 16 102 0.88% | 30 986 30 807 0.58% | 15 322 15 011 2.07% | 14 457 14 534 -0.53% | 29 779 29 914 -0.45% | 14 274 14 256 0.13% | 14 938 | 28 937 29 318 -1.3% | 14 399 14 370 0.21% | 13 153 | 29 689 | 14 770 | 15 205 | 30 904 | 15 035 | 30 225 | 30 835 |
EBIT Million CHF | Released Forecast Spread | 10 116 10 525 -3.89% | 11 766 11 824 -0.49% | 9 770 9 915 -1.46% | 11 652 11 715 -0.53% | 10 245 11 539 -11.21% | 12 668 12 024 5.35% | 9 505 9 639 -1.39% | 10 911 11 057 -1.32% | 8 329 9 168 -9.15% | 10 409 | 9 634 | ||||||||||||||||
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 6 260 9 758 -35.85% | 10 181 10 632 -4.24% | 7 784 9 124 -14.68% | 9 887 10 773 -8.22% | 7 511 10 155 -26.04% | 10 985 11 047 -0.56% | 5 342 9 016 -40.75% | 9 174 10 510 -12.71% | 4 905 8 786 -44.17% | 8 930 | 9 368 | ||||||||||||||||
Net income Million CHF | Released Forecast Spread | 4 878 6 896 -29.26% | 8 079 8 713 -7.27% | 6 216 7 084 -12.25% | 7 803 8 526 -8.48% | 6 127 7 703 -20.46% | 8 530 8 216 3.82% | 3 891 6 862 -43.3% | 7 137 7 896 -9.61% | 4 361 6 781 -35.69% | 7 294 | 7 071 | ||||||||||||||||
EPS CHF | Released Forecast Spread | 5,63 7,56 -25.53% | 9,32 9,70 -3.92% | 7,20 8,06 -10.64% | 9,05 9,29 -2.58% | 7,15 9,30 -23.12% | 10,5 10,0 5.14% | 4,83 7,87 -38.6% | 8,87 9,42 -5.81% | 5,44 8,43 -35.47% | 8,91 | 8,82 | ||||||||||||||||
Announcement Date | 30/01/20 | 23/07/20 | 04/02/21 | 22/07/21 | 03/02/22 | 03/02/22 | 25/04/22 | 21/07/22 | 21/07/22 | 18/10/22 | 02/02/23 | 02/02/23 | 27/04/23 | 27/07/23 | 27/07/23 | 01/11/23 | - | 01/02/24 | - | - | - | - | - | - | - | - | - |
Past sector events for Roche Holding AG
Today | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
16/07/2024 | CAMURUS AB: Q2 2024 Earnings Release |
11/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
10/07/2024 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
09/07/2024 05:05 pm | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
04/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
02/07/2024 02:35 pm | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ROG Stock
- ROG Stock
- Calendar Roche Holding AG